|
Mar 2020 |
Rabies in the African Civet: An Incidental Host for Lyssaviruses? |
Viruses |
Research funded by EVAg, Published by EVAg partner |
|
Jan 2022 |
Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor |
Sensors & Diagnostics |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2020 |
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis |
Nature Communications |
Research funded by EVAg, Published by EVAg partner |
|
Jun 2021 |
Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein |
Water Research |
Research funded by EVAg, Published by EVAg end-user |
|
Dec 2018 |
Re-visiting the evolution, dispersal and epidemiology of Zika virus in Asia |
Emerging Microbes & Infections |
Research funded by EVAg, Published by EVAg partner |
|
Aug 2021 |
Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs |
The Journal of Molecular Diagnostics |
Research funded by EVAg, Published by EVAg partner |
|
Oct 2018 |
Reassortment events in the evolution of hantaviruses |
Virus Genes |
Research funded by EVAg, Published by EVAg partner |
|
Oct 2017 |
Regulation of NF-κB by the p105-ABIN2-TPL2 complex and RelAp43 during rabies virus infection |
PLoS Pathogens |
Research funded by EVAg, Published by EVAg partner |
|
May 2018 |
Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome |
Emerging Microbes & Infections |
Research funded by EVAg, Published by EVAg partner |
|
Oct 2020 |
Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses |
Antiviral Research |
Research funded by EVAg, Published by EVAg end-user |
|
Feb 2018 |
Reply to Baylis et al., “External Quality Assessment (EQA) of Molecular Detection of Zika Virus: Value of the 1st World Health Organization International Standard” |
Journal of Clinical Microbiology |
Research funded by EVAg, Published by EVAg partner |
|
Oct 2019 |
Rescue of Replication-Competent ZIKV Hidden in Placenta-Derived Mesenchymal Cells Long After the Resolution of the Infection |
Open Forum Infectious Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Jan 1995 |
Resistance toTospoviruses inNicotiana benthamianaTransformed with the N Gene of Tomato Spotted Wilt Virus: Correlation Between Transgene Expression and Protection In Primary Transformants |
Molecular Plant-Microbe Interactions |
Research funded by EVAg, Published by EVAg end-user |
|
Jul 2018 |
Role of biobanks in the study of population immunity |
Journal Infectology |
Research funded by EVAg, Published by EVAg partner |
|
Apr 2021 |
Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen |
Journal of Clinical Medicine |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2017 |
Sand fly and Leishmania spp. survey in Vojvodina (Serbia): first detection of Leishmania infantum DNA in sand flies and the first record of Phlebotomus (Transphlebotomus) mascittii Grassi, 1908 |
Parasites & Vectors |
Research funded by EVAg, Published by EVAg partner |
|
Mar 2016 |
Sandfly-Borne Phlebovirus Isolations from Turkey: New Insight into the Sandfly fever Sicilian and Sandfly fever Naples Species |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Feb 2019 |
Sandfly-Borne Viruses of Demonstrated/Relevant Medical Importance |
Vectors and Vector-Borne Zoonotic Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Apr 2023 |
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel |
Biomedicines |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Dec 2020 |
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma |
|
Research funded by EVAg, Published by EVAg end-user |
|
Jan 2021 |
SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring |
Science of The Total Environment |
Research funded by EVAg, Published by EVAg partner |
|
Aug 2020 |
SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February–March 2020 |
Emerging Infectious Diseases |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Apr 2021 |
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus |
Viruses |
Research funded by EVAg, Published by EVAg partner |
|
Jun 2021 |
SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 |
PLoS ONE |
Research funded by EVAg, Published by EVAg end-user |
|
Nov 2017 |
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection |
Journal of Virology |
Research funded by EVAg, Published by EVAg partner |
|
May 2020 |
Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies |
Emerging Infectious Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2017 |
Serological association between Leishmania infantum and sand fly fever Sicilian (but not Toscana) virus in sheltered dogs from southern Portugal |
Parasites & Vectors |
Research funded by EVAg, Published by EVAg partner |
|
Feb 2019 |
Serological evidence of infection with dengue and Zika viruses in horses on French Pacific Islands |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Oct 2016 |
Seroprevalence of Sandfly‐Borne Phleboviruses Belonging to Three Serocomplexes (Sandfly fever Naples, Sandfly fever Sicilian and Salehabad) in Dogs from Greece and Cyprus Using Neutralization Test |
PLoS Neglected Tropical Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Jul 2021 |
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned |
Clinical Microbiology and Infection |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Jan 2021 |
Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test |
Viruses |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2016 |
Seroprevalence of Toscana virus in dogs from Corsica, France |
Parasites & Vectors |
Research funded by EVAg, Published by EVAg partner |
|
Jul 2020 |
Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients |
Emerging Infectious Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Feb 2020 |
Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group |
|
Research funded by EVAg, Published by EVAg partner |
|
Jul 2020 |
Shortlisting SARS‐CoV‐2 Peptides for Targeted Studies from Experimental Data‐Dependent Acquisition Tandem Mass Spectrometry Data |
PROTEOMICS |
Research funded by EVAg, Published by EVAg end-user |
|
Jan 2020 |
Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines |
Emerging Microbes & Infections |
Research funded by EVAg, Published by EVAg end-user |
|
Dec 2016 |
Simple reverse genetics systems for Asian and African Zika viruses |
Scientific Reports |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Jan 2020 |
Sloths host Anhanga virus‐related phleboviruses across large distances in time and space |
Transboundary and Emerging Diseases |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2020 |
Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro |
Molecules |
Research funded by EVAg, Published by EVAg end-user |
|
Jan 2018 |
Stress-induced unfolded protein response contributes to Zika virus–associated microcephaly |
Nature Neuroscience |
Research funded by EVAg, Published by EVAg end-user |
|
Jul 2019 |
Structural basis for catalysis and substrate specificity of a 3C-like cysteine protease from a mosquito mesonivirus |
Virology |
Research funded by EVAg, Published by EVAg partner |
|
Feb 2016 |
Structural characterization of the N-terminal part of the MERS-CoV nucleocapsid by X-ray diffraction and small-angle X-ray scattering |
Acta Crystallographica Section D Structural Biology |
Research funded by EVAg, Related to EVAg product, Published by EVAg partner |
|
Mar 2023 |
Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial |
eClinicalMedicine |
Research funded by EVAg, Published by EVAg end-user |
|
Apr 2017 |
Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2′-modified nucleotide analogues |
Antiviral Research |
Research funded by EVAg, Published by EVAg partner |
|
Mar 2018 |
SuPReMe: a rapid reverse genetics method to generate clonal populations of recombinant RNA viruses |
Emerging Microbes & Infections |
Research funded by EVAg, Published by EVAg partner |
|
Dec 2020 |
Syncytia formation by SARS‐CoV‐2‐infected cells |
The EMBO Journal |
Research funded by EVAg, Published by EVAg partner |
|
Jan 2019 |
Taxonomy of Viruses |
Reference Module in Biomedical Sciences |
Research funded by EVAg, Published by EVAg partner |
|
Feb 2021 |
Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus |
Viruses |
Research funded by EVAg, Published by EVAg partner |
|
Apr 2016 |
The 3.8 A resolution cryo-EM structure of Zika virus |
Science |
Research funded by EVAg, Published by EVAg end-user |
|
Aug 1996 |
The 5'-terminal region of a tombusvirus genome determines the origin of multivesicular bodies |
Journal of General Virology |
Research funded by EVAg, Published by EVAg end-user |
